List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Dr D. Sreedhar
Gen Da Chang
Lori Daane
Roger Dabbah
Srinivas S. Dagalur
Sumeet Dagar
Wei-Guo Dai
Jagdish Dalal
Martin Dallas
Lloyd Dalton
Mark Dalziel
N. Damodharan
John Danese
Benjamin Danso
Olivier Dapremont
Rob Darrington
Nandita G. Das, PhD
Surajit Das
Thomas Dassinger
Nipun Davar
Aaron Davidson
Antony N. Davies
Paul Davies
Craig J. Davies Cutting
Bruce Davis
Kelly Davis
Stephen J. Davis
Mark Davison
Thomas De Beer
Gerald De Fontenay
Ignace De Ridder
Melgardt M. de Villiers
Steve Deakin
Jacqueline DeBellis
Reno Debono, PhD
Nicolas Debruyne
Steve Deegan
P. S. Deepthi
Fran l. Degrazio
Frances DeGrazio
Motonari Deguchi
Degussa Pharma Polymers
Christie Deitz
Bruno Delagneau, MD
Patrick P. DeLuca
Christopher C. DeMerlis
Gang Deng
Richard Denk
Aline Denton
Kate Denton
Nandu Deorkar
Evelyn F. Der
Layla S. Derreja
Rachel Derrig-Vanzie
B.G. Desai
Ranjit Deshmukh
Amelie Desire
Anthony J. DeStefano, PhD
Anthony DeStefano
Cadnel Detchou
Pieter Deurinck
Dipankar Dey
K. Dhawan
S. Dhawan
Vinny Dhopeshwarkar
Frank Diana
Lee Dickinson
Kristie J. Diebold
Myron Diener
William Dierick
John DiLoreto
Jay DiMare
James C. DiNunzio
Jeffrey Dinyer
Ralph M. Dioguardi
Grace Discovery Sciences
Andrew Diston
OBK Water – Division of OBK Technology Ltd.
Andrew Dixon
Anne Marie Dixon
Dorian Dixon
Dr. Dorian Dixon
Keith Dixon
Dejan Djuric
Guillaume Doane
Jochen Dobberstein
Luca Dobetti
John Docherty
Kai Doderer
Steve Doherty
Eleni Dokou
Reuben D. Domike
Liang C. Dong
Jon Donovan
D. Doolittle
Professor Dorian Dixon
Craig Dorschel
Bob Dotterer
William H. Doub
George Dougherty
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here